Fabian Sierra Morales, MD, Igor Koralnik, MD and Jacob A. Sloane, MD PhD, Neurology, Beth Israel Deaconess Medical Center, Boston, MA

Fred Lublin, MD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC3, Giancarlo Comi, MD4, Stephen L Hauser, MD5, Krzysztof Selmaj, MD, PhD6, Anthony Traboulsee, MD, FRCPC7, Peter Chin, MD8, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Gaelle Klingelschmitt, MSc9, Donna Masterman, MD8, Ludwig Kappos, MD, PhD10 and Hans-Peter Hartung, MD, FRCP, FAAN, FANA11, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)University of California, San Franscisco, CA, (6)Medical University of Lodz, Lodz, Poland, (7)University of British Columbia, Vancouver, BC, Canada, (8)Genentech, Inc., South San Francisco, CA, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)University Hospital Basel, Basel, Switzerland, (11)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Fred Lublin, MD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC3, Giancarlo Comi, MD4, Hans-Peter Hartung, MD, FRCP, FAAN, FANA5, Stephen L Hauser, MD6, Krzysztof Selmaj, MD, PhD7, Anthony Traboulsee, MD, FRCPC8, Peter Chin, MD9, Paulo Fontoura, MD, PhD10, Hideki Garren, MD, PhD10, Gaelle Klingelschmitt, MSc10, Donna Masterman, MD9 and Ludwig Kappos, MD, PhD11, (1)Icahn School of Medicine at Mount Sinai, New York, NY, (2)NeuroRx Research, Montreal, QC, Canada, (3)McGill University, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (6)University of California, San Franscisco, CA, (7)Medical University of Lodz, Lodz, Poland, (8)University of British Columbia, Vancouver, BC, Canada, (9)Genentech, Inc., South San Francisco, CA, (10)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (11)University Hospital Basel, Basel, Switzerland

Chris M Kozma, PhD1, Frederick Munschauer, MD2 and Amy L Phillips, PharmD2, (1)CK Consulting Associates, LLC, Saint Helena Island, SC, (2)EMD Serono, Inc., Rockland, MA

Guosheng Yin, PhD1, Xiangyi Meng, PhD2 and M. Zahur Islam, PhD2, (1)The University of Hong Kong, Hong Kong, Hong Kong, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Janet Moores, RN, BN, MBA, University of Calgary MS Clinic, Calgary, AB, Canada

Jeffrey B English, MD1, Sophia Strickland, pre-medical student2 and Patrick J English, pre-business student2, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Clinical Research, Multiple Sclerosis Center of Atlanta, Atlanta, GA

Jeffrey B English, MD1, Debra K Johnson, RN2, Mitzi J. Williams, MD1 and Donna M Court, MN, RN2, (1)Multiple Sclerosis Center of Atlanta, Atlanta, GA, (2)Clinical Research, Multiple Sclerosis Center of Atlanta, Atlanta, GA

Jennifer Smrtka, MSN, ARNP-BC, MSCN, Neurology, University of Miami, Miami, FL and Lori Mayer, DNP, MSN, RN, MSCN, MS Clinic of Central Texas/Central Texas Neurology Consultants, Round Rock, TX

Kathleen Costello, MS, ANP-BC, MSCN, Vice President, Healthcare Access, National Multiple Sclerosis Society, New York, NY, Helmut Butzkueven, MBBS, PhD, Melbourne Brain Centre, Royal Melbourne Hospital, University of Melbourne, Parkville, VIC, Australia, Suhayl Dhib-Jalbut, MD, Department of Neurology, RUTGERS Robert Wood Johnson Medical School, New Brunswick, NJ, Jeremy Hobart, PhD FRCP, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, United Kingdom of Great Britain and Northern Ireland, Gisela Kobelt, PhD, European Health Economics, Mulhouse, France, George Pepper, ., Shift.ms, Leeds, United Kingdom of Great Britain and Northern Ireland, Maria Pia Sormani, PhD, Biostatistics Unit, University of Genoa, Genoa, Italy, Christoph Thalheim, ., Patient Advocate in Multiple Sclerosis, Brussels, Belgium, Anthony Traboulsee, MD, FRCPC, Department of Medicine, University of British Colombia, Vancouver, BC, Canada, Timothy Vollmer, MD, Department of Neurology, University of Colorado Denver, Aurora, CO and Gavin Giovannoni, MBBCh, PhD, Queen Mary University London, Barts and The London School of Medicine, London, United Kingdom; Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom of Great Britain and Northern Ireland

Krzysztof Selmaj, MD, PhD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC2, Giancarlo Comi, MD4, Hans-Peter Hartung, MD, FRCP, FAAN, FANA5, Stephen L Hauser, MD6, Fred Lublin, MD7, Anthony Traboulsee, MD, FRCPC8, Nicole Mairon, MD9, Peter Chin, MD10, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Gaelle Klingelschmitt, MSc9, Donna Masterman, MD10 and Ludwig Kappos, MD, PhD11, (1)Medical University of Lodz, Lodz, Poland, (2)McGill University, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)University Vita-Salute San Raffaele, Milan, Italy, (5)Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany, (6)University of California, San Franscisco, CA, (7)Icahn School of Medicine at Mount Sinai, New York, NY, (8)University of British Columbia, Vancouver, BC, Canada, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)Genentech, Inc., South San Francisco, CA, (11)University Hospital Basel, Basel, Switzerland

Laurie Millar, PhD, Carrie Li, PhD, Henry Bennett, BSc and Hideki Garren, MD, PhD, F. Hoffmann-La Roche Ltd., Basel, Switzerland

Lori Mayer, DNP, MSN, RN, MSCN1, Edward J. Fox, MD, PhD1, Christopher LaGanke, MD2, Bhupendra Khatri, MD3, Ann D Bass, MD4, David H Margolin, MD, PhD5, Linda Kasten, MA6 and Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN7, (1)Central Texas Neurology Consultants, Round Rock, TX, (2)North Central Neurology Associates, Cullman, AL, (3)Wheaton Franciscan Regional MS Center, Milwaukee, WI, (4)Neurology Center of San Antonio, San Antonio, TX, (5)Genzyme, a Sanofi company, Cambridge, MA, (6)PROMETRIKA, LLC, Cambridge, MA, (7)Neurology Associates, PA, Maitland, FL

Madé Wenten, PhD, MPH, Teesta Soman, MD, MBA, Cathy Lally, MSPH, Maneesh Juneja, BSc, Susan Eaton, MSPH, MT (ASCP), Claudia Prada, MD, PhD and Anne Dilley, BA, MPH, PhD, Biogen, Cambridge, MA

Roochi S Ghodasara, MD1, Madelyn B Rarick, BSN1, Miranda C Mosley, BS1, Rachel A Morgan, BA1, S.R. Sparrow Smith, BS, MA1, Laurel Kagan, NP1, Daniel Kantor, MD2,3, Joy Derwenskus, DO, MS1 and Samuel F. Hunter, MD, PhD1,2, (1)Advanced Neurosciences Institute, Franklin, TN, (2)NeuroNexus Center – Novel Pharmaceutics Institute, Franklin, TN, (3)Kantor Neurology, Coconut Creek, FL

Mark Cascione, MD1, Bruce AC Cree, MD, PhD2, Daniel Wynn, MD3, Xiangyi Meng, PhD4, Lesley Schofield, PhD4 and Nadia Tenenbaum, MD4, (1)Tampa Neurology Associates, South Tampa Multiple Sclerosis Center, South Tampa, FL, (2)University of California San Francisco, San Francisco, CA, (3)Consultants in Neurology MS Center, Northbrook, IL, (4)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Mark S Freedman, MD1, Ludwig Kappos, MD2, Giancarlo Comi, MD3, Aaron E Miller, MD4, Jerry Wolinsky, MD5, Karthinathan Thangavelu, PhD6, Philippe Truffinet, MD7, Myriam Benamor, MD7, Pascal Rufi, MD7 and Paul O’Connor, MD8, (1)University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, ON, Canada, (2)University Hospital Basel, Basel, Switzerland, (3)University Vita-Salute San Raffaele, Milan, Italy, (4)Icahn School of Medicine at Mount Sinai, New York, NY, (5)University of Texas Health Science Center at Houston, Houston, TX, (6)Genzyme, a Sanofi company, Cambridge, MA, (7)Genzyme, a Sanofi company, Chilly-Mazarin, France, (8)University of Toronto, Toronto, ON, Canada

Michael A Mercurio, MD1, Michael Y Ko, MD2, Roumen Balabanov, MD3, Jennifer A Strong, MS3 and Dusan Stefoski, MD2, (1)Neurology, Rush University Medical Center, Chicago, IL, (2)Rush University Medical Center, Chicago, IL, (3)Rush University Multiple Sclerosis Center, Chicago, IL

Michelle A Allan, RN BA Nursing GCert MS1 and Lindsay Grant, B.Pharm1,2, (1)Monash Neurology, Monash Health, Melbourne, Australia, (2)Medical, Biogen, Sydney, Australia

Aaron Boster, MD1, Jacqueline Nicholas, MD, MPH2, Ning Wu, Ph.D.3, Wei-Shi Yeh, PhD3, Monica A Fay, PharmD4, Michael R Edwards, PhD5, Ming-Yi Huang, PhD3 and Andrew Lee, PhD3, (1)OhioHealth Neurological Physicians, Columbus, OH, (2)Health Economics & Outcomes Research, Novartis Pharmaceutical Corporation, East Hanover, NJ, (3)Global Health Economics and Outcomes Research, Biogen, Cambridge, MA, (4)US Medical Affairs, Biogen, Weston, MA, (5)Global Medical Affairs, Biogen, Cambridge, MA

Demetrios Konstas, MD1, Natalie K Moreo, MD1, Chetan P Gandhy, MD1, Michelle Lyman, MSII2, Doris Deng, MSII2, Robert Soares, BS1, Steven Aradi, MD3 and Derrick S Robertson, MD1, (1)Neurology, University of South Florida, Tampa, FL, (2)University of South Florida College of Medicine, Tampa, FL, (3)Neurology, University of Pennslyvania Perelman School of Medicine, Philadelphia, PA

Demetrios Konstas, MD1, Natalie K Moreo, MD1, Chetan P Gandhy, MD1, Doris Deng, MSII2, Michelle Lyman, MSII2, Robert Soares, BS1 and Derrick S Robertson, MD1, (1)Neurology, University of South Florida, Tampa, FL, (2)University of South Florida College of Medicine, Tampa, FL

Nicholas Everage, PhD1, Claudia Prada, MD, PhD1, Shifang Liu, PhD1, Konstantin Balashov, MD, PhD, FAAN2, Richard Macdonell, MD, FRACP3, Jörg Windsheimer, MD4 and Kathryn Giles, MD, MSc, FRCPC5, (1)Biogen, Cambridge, MA, (2)Robert Wood Johnson Medical School, New Brunswick, NJ, (3)Department of Neurology, Austin Health, Univ. of Melbourne, Melbourne, Australia, (4)Praxis für Neurologie und Psychiatrie, Nürnberg, Germany, (5)Cambridge Memorial Hospital, Cambridge, ON, Canada

Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, MS Center of Greater Orlando, Maitland, FL

Robert Kuhelj, PhD1, Gurpreet Deol-Bhullar, BSc, OT1, Monika Garas, PhD1, Peter Chin, MD2, Stephen L Hauser, MD3 and Xavier Montalban, MD, PhD4, (1)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (2)Genentech, Inc., South San Francisco, CA, (3)University of California, San Franscisco, CA, (4)Hospital Vall d’Hebron University, Barcelona, Spain

Roochi S Ghodasara, MD1, Miranda C Mosley, BS1, Rachel A Morgan, BA1, S.R. Sparrow Smith, BS, MA1, Madelyn B Rarick, BSN1, Laurel Kagan, NP1, Daniel Kantor, MD1, Joy Derwenskus, DO, MS1 and Samuel F. Hunter, MD, PhD2, (1)Neurology, Advanced Neurosciences Institute, Franklin, TN, (2)NeuroNexus Center – Novel Pharmaceutics Institute, Franklin, TN

Shannon Ritter, MS1, Anthony T Reder, MD2, Daniela Piani Meier, PhD3, Davorka Tomic, PhD3 and Bruce AC Cree, MD, PhD4, (1)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (2)University of Chicago, Chicago, IL, (3)Novartis Pharma AG, Basel, Switzerland, (4)University of California San Francisco, San Francisco, CA

Steven H Nye, Ph.D., Discovery, ENDECE Neural, LLC, Mequon, WI and James G Yarger, Ph.D., ENDECE Neural, LLC, Mequon, WI

Tania A Reyna, MD1, Tony Sharp, PA2, Cecilie Fjeldstad, PhD2, Jennifer Smith, PA2 and Gabriel Pardo, MD2, (1)Oklahoma Medical Research Foundation, Oklahoma City, OK, (2)MS Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK

Virginia Devonshire, MD, Department of Neurology, University of British Columbia, Vancouver, BC, Canada, Anthony Feinstein, MPhil, PhD, FRCP, Department of Psychiatry, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada and Alan Gillett, PhD, EMD Serono, Mississauga, ON, Canada

Xavier Montalban, MD, PhD1, Douglas L Arnold, MD2,3, Amit Bar-Or, MD, FRCPC2, Jérôme de Seze, MD, PhD4, Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath5, Bernhard Hemmer, MD6,7, Kottil Rammohan, MD8, Nicole Mairon, MD9, Peter Chin, MD10, Paulo Fontoura, MD, PhD9, Hideki Garren, MD, PhD9, Donna Masterman, MD10, Annette Sauter, MD9 and Jerry Wolinsky, MD11, (1)Vall d’Hebron University Hospital, Barcelon, Spain, (2)McGill University, Montreal, QC, Canada, (3)NeuroRx Research, Montreal, QC, Canada, (4)University Hospital of Strasbourg, Strasbourg, France, (5)Queen Mary University of London, London, United Kingdom of Great Britain and Northern Ireland, (6)Munich Cluster for Systems Neurology (SyNergy), Munich, Germany, (7)Technische Universität München, Munich, Germany, (8)University of Miami, Miami, FL, (9)F. Hoffmann-La Roche Ltd., Basel, Switzerland, (10)Genentech, Inc., South San Francisco, CA, (11)University of Texas Health Science Center at Houston, Houston, TX

Zahra Almosawi, BSc, Amal Almahroos, Bsc, Reem Abdulla, Bsc, Ayman Mohamed, BSc, Hawra Alalwan, BSc, Ahmmed Almubarak, BSc, Fajer Alammadi, BSc, Amer Kamal, Professor and Ahmed Al-Mahrezi, BSc, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

Aliza Ben-Zacharia, DNP, ANP, MSCN, Neurology, Mount Sinai Hospital, New York, NY

Dolly B Roy, MD PhD, Neurology, Northridge Hospital Medical Center, Northridge, CA

Elizabeth W. Triche, PhD, Department of Epidemiology, Brown University School of Public Health, Providence, RI, Jennifer A. Ruiz, DPT, Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT and Albert C. Lo, MD, PhD, Departments of Neurology and Engineering, Brown University, Providence, RI

Elizabeth W. Triche, PhD1,2, Carolyn J. St. Andre, BS1, Lindsay O. Tuttle, MPH1, Jennifer A. Ruiz, DPT1 and Albert C. Lo, MD, PhD1, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Katelyn S. Kavak, MS1, Barbara E. Teter, PhD, MPH2, Caila B Vaughn, MPH1, Keith R Edwards, MD, FAAN3, Patricia K Coyle, MD3, Lore Garten, MD4, Malcolm Gottesman, MD5, Burk Jubelt, MD6, Ilya Kister, MD3, Lauren Krupp, MD7, Jessica F Robb, MD3, Robert Zivadinov, MD, PhD3 and Bianca Weinstock-Guttman, MD3, (1)Jacobs MS Center of Treatment and Research, Buffalo, NY, (2)Department of Neurology, University at Buffalo, Buffalo, NY, (3)New York State Multiple Sclerosis Consortium, Buffalo, NY, (4)MS Center of Northeastern New York, Latham, NY, (5)Winthrop Comprehensive MS Care Center, Mineola, NY, (6)SUNY Upstate Medical University, Syracuse, NY, (7)NYU Langone Medical Center, New York, NY

Tanuja Chitnis, MD1, Jennifer Graves, MD, PhD2, Cody S Olsen, MS3, Jayne Ness, MD4, Lauren Krupp, MD5, Anita Belman, MD5, Moses Rodriguez, MD6, Jan Tillema, MD7, Tim Lotze, MD, PhD8, Mark Gorman, MD9, Leslie Benson, MD10, Bianca Weinstock-Guttman, MD11, Greg Aaen, MD12, John Rose, MD13, T. Charles Casper, PhD14 and Emmanuelle Waubant, MD, PhD2, (1)Massachusetts General Hospital for Children, Boston, MA, (2)UCSF Pediatric MS Center, San Francisco, CA, (3)Neurology, University of Utah, Salt Lake City, UT, (4)Alabama Pediatric MS Center, Birmingham, AL, (5)Lourie Center for Pediatric MS, Stony Brook Children’s Hospital, Stony Brook, NY, (6)Department of Neurology, Mayo Clinic, Rochester, MN, (7)Pediatric MS Center, Mayo Clinic, Rochester, MN, (8)Texas Children’s Hospital, Houston, TX, (9)Massachusetts General Hospital, Partners Pediatric MS Center, Boston, MA, (10)Boston Children’s Hospital, Boston, MA, (11)New York State Multiple Sclerosis Consortium, Buffalo, NY, (12)Department of Child Neurology, Loma Linda University, Loma Linda, CA, (13)Department of Neurology University of Utah and Neurovirology Research Laboratory VASLCHCS, Imaging and Neuroscience Center, Salt Lake City, UT, (14)Department of Pediatrics, University of Utah, Salt Lake City, UT

Ana M Canzonieri, DRA, Mauricio O Bando Sr., Sr, Jean I Francisco, Sr, Fernanda M Marques, Sra and Lucas F.R dos Santos Sr., student, Research, ABEM . Brazilian Association Multiple Sclerosis, São Paulo, Brazil

Carol Swetlik, BA1, Sarah M Planchon, PhD, CCRP2, Jeffrey A Cohen, MD2 and Daniel Ontaneda, MD2, (1)Cleveland Clinic Lerner College of Medicine, Cleveland, OH, (2)The Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH